-

GEMI Investor Alert: Gemini Space Station Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Analysts Allegedly Downgraded Misled Stock: Levi & Korsinsky

Wall Street Reassessment: Analyst Opinion Evolution on GEMI

NEW YORK--(BUSINESS WIRE)--On February 5, 2026, Evercore ISI slashed its price target on Gemini Space Station, Inc. (NASDAQ: GEMI) by 50%, from $15.00 to $10.00, and downgraded the stock from outperform to in line. Within two weeks, Truist Securities cut its target 46%, Needham & Co. cut 57%, and Rosenblatt cut 55%. Find out if you qualify to recover losses from GEMI's decline. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Shareholders who purchased GEMI securities between September 12, 2025 and February 17, 2026 saw the stock collapse from its $28.00 IPO price to $6.585, a total loss of $21.415 per share (76.48%). The lead plaintiff deadline is May 18, 2026.

The Downgrades Begin

The sell-side reassessment began immediately after the Company disclosed its pivot to "Gemini 2.0" on February 5, 2026. The lawsuit contends that analysts had relied on representations about international expansion and crypto exchange growth that proved to be overstated. Evercore ISI noted that "investors are more interested in growth given the early stage that the company and sector are both in," signaling that the pivot undermined the investment thesis analysts had built on management's prior statements.

Execution Concerns on Wall Street

The February 17, 2026 disclosures triggered a second wave of downgrades:

  • Truist Securities downgraded GEMI from buy to hold, cutting its price target from $13.00 to $7.00, and warned the announcement "could result in more investors becoming concerned about Gemini's solvency"
  • Needham & Co. reduced its target from $23.00 to $10.00, characterizing the executive departures as "a major leadership restructuring" with "worsened" expenses
  • Rosenblatt cut its target from $26.00 to $11.50, stating: “[j]ust after what at the time felt like a successful IPO, Gemini is now in full restructuring mode"

Why Analyst Shifts Matter for Investors

As alleged in the action, the analyst models that supported GEMI's IPO valuation were built on specific management representations: 20%-25% compound MTU growth, international expansion across 30 European countries and Australia, and a core crypto exchange business model. When those representations collapsed, analyst coverage followed.

"When analyst expectations are built on incomplete or misleading company disclosures, the resulting corrections can cause significant investor harm. The speed and severity of the GEMI downgrades reflect how fundamentally the market's understanding of this company changed." -- Joseph E. Levi, Esq.

Speak with an attorney about recovering your GEMI investment losses or call (212) 363-7500.

LEAD PLAINTIFF DEADLINE: May 18, 2026

Levi & Korsinsky, LLP, Top 50 securities litigation firm (ISS, seven consecutive years). Over 70 professionals. Hundreds of millions recovered for investors.

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

Levi & Korsinsky, LLP

NASDAQ:GEMI

Release Versions

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

More News From Levi & Korsinsky, LLP

EYPT Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into EyePoint Pharmaceuticals (EYPT)

NEW YORK--(BUSINESS WIRE)--Roughly seven out of every ten dollars invested in EyePoint Pharmaceuticals (NASDAQ: EYPT) common stock was wiped out when shares fell nearly 67% following the Company's disclosure that DURAVYU missed the prespecified primary endpoint in the Phase 3 LUGANO wet AMD trial. If you held EYPT shares through that decline, you are encouraged to have your EYPT losses reviewed now. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at...

GLOB Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Globant (GLOB)

NEW YORK--(BUSINESS WIRE)--Shareholders of Globant (NYSE: GLOB) absorbed a sharp decline in the shares after the Company's Q2 2026 earnings release, which reported revenue of approximately $614.4 million and a reduced full-year 2026 revenue forecast. Investors who lost money on GLOB are encouraged to request a review of your GLOB losses now. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. The reported quarter came in below street...

PRIM Deadline Alert: Levi & Korsinsky Reminds Primoris Services Corporation (PRIM) Investors of Securities Class Action Deadline on September 21, 2026

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP notifies investors in Primoris Services Corporation (NYSE: PRIM) that a class action has been filed on behalf of shareholders who purchased securities between August 5, 2025 and June 22, 2026. See if you could be eligible to recover or call (212) 363-7500.PRIM fell $23.39 per share, or 21.6%, from $108.34 to $84.95 on June 23, 2026. The lead plaintiff deadline is September 21, 2026.Primoris Timeline Disclosure Events Alleged in the ComplaintTh...
Back to Newsroom